Comparative outcomes of COVID-19 in patients with primary Sjögren’s syndrome treated with hydroxychloroquine versus methotrexate: a retrospective cohort study
Background People with rheumatic diseases are considered at risk for severe coronavirus disease 2019 (COVID-19) because of their underlying abnormal immune responses and frequent disease-modifying antirheumatic drug (DMARD) use. We aimed to explore COVID-19 outcomes in patients with primary Sjögren’...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Annals of Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2527361 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|